Literature DB >> 7947048

How to assess the rate of progression of chronic renal failure in children?

N M Gretz1.   

Abstract

Methodology for assessing progression of chronic renal failure and performing and analysing trials has never been a favourite topic in nephrology. The aim of this paper is to discuss from a statistician's point of view the advantages and disadvantages of different direct (glomerular filtration rate, creatinine clearance, reciprocal and serum creatinine) and indirect (need of renal replacement therapy, halving of glomerular filtration rate, doubling of serum creatinine) markers of renal function, and their statistical evaluation. The use of cross-tabulation, regression analyses/slope techniques and survival analyses for this purpose is discussed. Furthermore, a new approach for the evaluation of progression, the so-called progression charts, is described in detail. This paper reveals that analysing progression of renal failure is not an easy task. However, there are a number of pragmatic approaches which seem to be suitable.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947048     DOI: 10.1007/bf00856550

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Discrepancy between circadian rhythms of inulin and creatinine clearance.

Authors:  B A van Acker; G C Koomen; M G Koopman; R T Krediet; L Arisz
Journal:  J Lab Clin Med       Date:  1992-09

Review 2.  Measurement of renal function in chronic renal disease.

Authors:  A S Levey
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

3.  Low-protein diet and chronic renal failure.

Authors: 
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

Review 4.  Dietary protein and renal function.

Authors:  A J King; A S Levey
Journal:  J Am Soc Nephrol       Date:  1993-05       Impact factor: 10.121

5.  Controlled low protein diets in chronic renal insufficiency: meta-analysis.

Authors:  D Fouque; M Laville; J P Boissel; R Chifflet; M Labeeuw; P Y Zech
Journal:  BMJ       Date:  1992-01-25

6.  Serial measurements of GFR in infants using the continuous iothalamate infusion technique. Southwest Pediatric Nephrology Study Group (SPNSG).

Authors:  M A Holliday; D Heilbron; A al-Uzri; J Hidayat; R Uauy; S Conley; J Reisch; R J Hogg
Journal:  Kidney Int       Date:  1993-04       Impact factor: 10.612

7.  Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis.

Authors:  F Manz; N Gretz
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

Review 8.  In defense of creatinine clearance.

Authors:  S Giovannetti; G Barsotti
Journal:  Nephron       Date:  1991       Impact factor: 2.847

9.  Determination of glomerular filtration rate (GFR) on two consecutive days using inulin in a single-sample plasma clearance method.

Authors:  L Schumann; P W Wüstenberg; B Hortian; H F Kühnle
Journal:  Clin Nephrol       Date:  1993-02       Impact factor: 0.975

10.  Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man.

Authors:  J Böhler; R Woitas; E Keller; P Reetze-Bonorden; P J Schollmeyer
Journal:  Am J Kidney Dis       Date:  1992-08       Impact factor: 8.860

View more
  4 in total

1.  Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree.

Authors:  H Omran; C Fernandez; M Jung; K Häffner; B Fargier; A Villaquiran; R Waldherr; N Gretz; M Brandis; F Rüschendorf; A Reis; F Hildebrandt
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Doubling of serum creatinine: is it appropriate as the endpoint for CKD? Proposal of a new surrogate endpoint based on the reciprocal of serum creatinine.

Authors:  Noriko Takeuchi; Emi Takenoshita; Fumino Kato; Tomoko Terajima; Makoto Ogawa; Satoshi Suzuki; Takayuki Fujii; Eriko Kobayashi; Tomoya Sakurada; Nobunori Satoh; Shiro Ueda
Journal:  Clin Exp Nephrol       Date:  2010-11-09       Impact factor: 2.801

3.  The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire.

Authors:  W G van't Hoff; N Gretz
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

4.  Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis.

Authors:  F Manz; N Gretz
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.